SCHEMBL27925575

SCHEMBL27925575

CC1(C)c2cnc(-c3nn(Cc4ccc(F)cc4F)c4ncccc34)nc2NC1C=O

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27907479 0.91 PDE5A (0.61) PDE5A
SCHEMBL27907471 0.88 PDE5A (0.54) PDE5A
SCHEMBL27907474 0.84 PDE5A (0.60) PDE5A
SCHEMBL27925563 0.84 PDE5A (0.58) PDE5A
SCHEMBL327115 0.83 PDE5A (0.66) PDE5A
SCHEMBL326635 0.79 PDE5A (0.62) PDE5A
SCHEMBL27907468 0.79 PDE5A (0.65) PDE5A
SCHEMBL27925558 0.79 PDE5A (0.61) PDE5A
SCHEMBL27979435 0.77 PDE5A (0.60) PDE5A
SCHEMBL27907475 0.77 PDE5A (0.60) PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103097387-B Ring-fused pyrimidines and triazines and use thereof for treating and/or preventing cardiovascular diseases 拜耳知识产权有限责任公司 2016-11-02 CN disclosed
CN-103097387-A Ring-fused pyrimidines and triazines and use thereof for treating and/or preventing cardiovascular diseases BAYER IP GMBH 2013-05-08 CN disclosed